{"id":"https://openalex.org/W2014559115","doi":"https://doi.org/10.1211/0022357001774057","title":"SM-20220, a Potent Na+/H+ Exchange Inhibitor, Improves Consciousness Recovery and Neurological Outcome Following Transient Cerebral Ischaemia in Gerbils","display_name":"SM-20220, a Potent Na+/H+ Exchange Inhibitor, Improves Consciousness Recovery and Neurological Outcome Following Transient Cerebral Ischaemia in Gerbils","publication_year":2000,"publication_date":"2000-04-01","ids":{"openalex":"https://openalex.org/W2014559115","doi":"https://doi.org/10.1211/0022357001774057","mag":"2014559115","pmid":"https://pubmed.ncbi.nlm.nih.gov/10813556"},"language":"en","primary_location":{"id":"doi:10.1211/0022357001774057","doi":"https://doi.org/10.1211/0022357001774057","is_oa":false,"landing_page_url":"https://doi.org/10.1211/0022357001774057","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051805201","display_name":"Yoshikazu Kuribayashi","orcid":"https://orcid.org/0009-0002-0123-133X","observed_orcids":["https://orcid.org/0009-0002-0123-133X"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yoshikazu Kuribayashi","raw_affiliation_strings":["Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053998193","display_name":"Natsuko Itoh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Natsuko Itoh","raw_affiliation_strings":["Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028423265","display_name":"Naotsugu Horikawa","orcid":"https://orcid.org/0000-0001-9948-1497","observed_orcids":["https://orcid.org/0000-0001-9948-1497"]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naotsugu Horikawa","raw_affiliation_strings":["Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,","institution_ids":["https://openalex.org/I31591830"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113589629","display_name":"Naohito Ohashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I31591830","display_name":"Sumitomo Dainippon Pharma (Japan)","ror":"https://ror.org/04sapgw72","country_code":"JP","type":"company","lineage":["https://openalex.org/I31591830"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naohito Ohashi","raw_affiliation_strings":["Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sumitomo Pharmaceuticals Research Center , 1\u201398, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-0022,","institution_ids":["https://openalex.org/I31591830"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051805201"],"corresponding_institution_ids":["https://openalex.org/I31591830"],"apc_list":{"value":2911,"currency":"GBP","value_usd":3839},"apc_paid":null,"fwci":2.5389,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.87051207,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"52","issue":"4","first_page":"441","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.8711000084877014,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14144","display_name":"Neurological Disease Mechanisms and Treatments","score":0.09510000050067902,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.018400000408291817,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/na-h-exchanger-inhibitor","display_name":"Na+/H+ exchanger inhibitor","score":0.8930000066757202},{"id":"https://openalex.org/keywords/na-h-exchanger","display_name":"Na+/H+ exchanger","score":0.4950000047683716},{"id":"https://openalex.org/keywords/transient-cerebral-ischemia","display_name":"transient cerebral ischemia","score":0.8730000257492065},{"id":"https://openalex.org/keywords/global-cerebral-ischemia","display_name":"global cerebral ischemia","score":0.9110000133514404},{"id":"https://openalex.org/keywords/recovery-of-consciousness","display_name":"consciousness recovery","score":0.6549999713897705},{"id":"https://openalex.org/keywords/neurological-outcome","display_name":"neurological outcome","score":0.9980000257492065},{"id":"https://openalex.org/keywords/brain-protection","display_name":"cerebral protection","score":0.7639999985694885},{"id":"https://openalex.org/keywords/carotid-occlusion","display_name":"carotid artery occlusion","score":0.781000018119812},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.8519999980926514},{"id":"https://openalex.org/keywords/mortality","display_name":"mortality","score":0.6159999966621399},{"id":"https://openalex.org/keywords/mongolian-gerbil","display_name":"Mongolian gerbil","score":0.765999972820282}],"concepts":[{"id":"https://openalex.org/C2780222073","wikidata":"https://www.wikidata.org/wiki/Q649817","display_name":"Gerbil","level":3,"score":0.8877899646759033},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.6693301796913147},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6258068680763245},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6251328587532043},{"id":"https://openalex.org/C2909286980","wikidata":"https://www.wikidata.org/wiki/Q4862390","display_name":"Cerebral ischaemia","level":3,"score":0.574333906173706},{"id":"https://openalex.org/C2775841333","wikidata":"https://www.wikidata.org/wiki/Q498179","display_name":"Middle cerebral artery","level":3,"score":0.41049063205718994},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3612523078918457},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2873876094818115}],"mesh":[{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002546","descriptor_name":"Ischemic Attack, Transient","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D002546","descriptor_name":"Ischemic Attack, Transient","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D003243","descriptor_name":"Consciousness","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005849","descriptor_name":"Gerbillinae","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D009422","descriptor_name":"Nervous System Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017923","descriptor_name":"Sodium-Hydrogen Exchangers","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1211/0022357001774057","doi":"https://doi.org/10.1211/0022357001774057","is_oa":false,"landing_page_url":"https://doi.org/10.1211/0022357001774057","pdf_url":null,"source":{"id":"https://openalex.org/S118304455","display_name":"Journal of Pharmacy and Pharmacology","issn_l":"0022-3573","issn":["0022-3573","2042-7158"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacy and Pharmacology","raw_type":"journal-article"},{"id":"pmid:10813556","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10813556","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacy and pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1486830961","https://openalex.org/W1536629235","https://openalex.org/W1972820685","https://openalex.org/W1983692432","https://openalex.org/W1993454280","https://openalex.org/W1995488111","https://openalex.org/W2001818372","https://openalex.org/W2023811880","https://openalex.org/W2025933623","https://openalex.org/W2031702150","https://openalex.org/W2034016319","https://openalex.org/W2052001691","https://openalex.org/W2075147562","https://openalex.org/W2081230957","https://openalex.org/W2096021091","https://openalex.org/W2149490590","https://openalex.org/W2149542102","https://openalex.org/W2400440254","https://openalex.org/W3105201033","https://openalex.org/W6712942590"],"related_works":["https://openalex.org/W2149490590","https://openalex.org/W2422051481","https://openalex.org/W2044041927","https://openalex.org/W1977346609","https://openalex.org/W2043476587","https://openalex.org/W1972678357","https://openalex.org/W3105770806","https://openalex.org/W2018212856","https://openalex.org/W2886401390","https://openalex.org/W3101190883"],"abstract_inverted_index":{"We":[0],"studied":[1],"the":[2,53,63,71,77,99],"cerebroprotective":[3],"effect":[4],"of":[5,41,73,101],"SM-20220":[6,42,60],"(N-(aminoiminomethyl)-1-methyl-1H-indole-2-carboxamide":[7],"methanesulphonate),":[8],"a":[9],"newly":[10],"synthesized":[11],"Na+/H+":[12],"exchanger":[13],"(NHE)":[14],"inhibitor,":[15],"in":[16,98],"Mongolian":[17],"gerbil":[18],"global":[19],"ischaemia.":[20],"Transient":[21],"cerebral":[22,102],"ischaemia":[23],"was":[24,80],"induced":[25],"by":[26,36,105],"clipping":[27],"both":[28],"common":[29],"carotid":[30],"arteries":[31],"for":[32],"30":[33],"min":[34],"followed":[35],"24h":[37],"reperfusion.":[38,69],"Intravenous":[39],"administration":[40],"(0.3":[43],"or":[44],"1.0":[45,74],"mg":[46,75],"kg(-1))":[47],"immediately":[48],"after":[49,68,86],"reperfusion":[50,87],"significantly":[51,81],"shortened":[52],"consciousness":[54,106],"recovery":[55],"time":[56],"(P":[57,88],"<":[58,89],"0.01).":[59,90],"also":[61],"improved":[62],"neurological":[64,109],"outcome":[65,110],"(McGraw's":[66],"scale)":[67],"At":[70],"dose":[72],"kg(-1),":[76],"mortality":[78],"rate":[79],"reduced":[82],"at":[83],"24":[84],"h":[85],"This":[91],"study":[92],"shows":[93],"that":[94,116],"NHE":[95],"is":[96],"involved":[97],"aggravation":[100],"function,":[103],"represented":[104],"recovery,":[107],"and":[108,115],"following":[111],"transient":[112],"forebrain":[113],"ischaemia,":[114],"its":[117],"inhibitor":[118],"may":[119],"exert":[120],"protective":[121],"effects":[122],"on":[123],"post-ischaemic":[124],"brain":[125],"damage.":[126]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}